secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001401914-26-000012
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience closes $100K Reg A offering of 20,000 units at $5/unit
----------------------------------------------------------------------

- Issued 20,000 Investor Units, each: one share Series A Convertible Preferred + two warrants for common stock.
- Gross proceeds of $100,000 from 20,000 units at $5.00 per unit.
- Investor warrants exercisable for up to 40,000 shares of common stock.
- Offering statement qualified by SEC on April 1, 2026; terms previously reported in Jan 29, 2026 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000012/0001401914-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000012/dare-20260417.htm
  HTML page:      https://secwatch.observer/filing/0001401914-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer